← back to search

Nicole Shonka

University of Nebraska Medical Center · US
Area of research
Genetics · Cancer Research
Research interest
Research interests include Glioma Diagnosis and Treatment, Cancer, Hypoxia, and Metabolism, ATP Synthase and ATPases Research, and Brain Metastases and Treatment.
h-index
21
citations
3,046
works
196
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

ONC201 (Dordaviprone) in Recurrent H3 K27M–Mutant Diffuse Midline Glioma
Journal of Clinical Oncology 2024cited by 85position: middledoi
Diffuse intrinsic pontine glioma (DIPG): A review of current and emerging treatment strategies
Cancer Letters 2024cited by 29position: middledoi
NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022
Journal of the National Comprehensive Cancer Network 2023cited by 215position: middledoi
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
Cancer Discovery 2023cited by 143position: middledoi
Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic <i>NF2</i> Mutations
Journal of Clinical Oncology 2022cited by 101position: middledoi
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network 2020cited by 556position: middledoi
Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201
Journal of Neuro-Oncology 2019cited by 194position: middledoi
NCCN Guidelines Insights: Central Nervous System Cancers, Version 1.2017
Journal of the National Comprehensive Cancer Network 2017cited by 230position: middledoi
Central Nervous System Cancers, Version 2.2014
Journal of the National Comprehensive Cancer Network 2014cited by 101position: middledoi
IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection
Neuro-Oncology 2013cited by 464position: middledoi
CLIN-NEURO/MEDICAL ONCOLOGY
Neuro-Oncology 2012cited by 2position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Frederick F. Lang · The University of Texas MD Anderson Cancer Center1 papers (2013–2013)Benjamin D. Fox · Tel Aviv University1 papers (2013–2013)— · 1 papers (2024–2024)Winson S. Ho · Brigham and Women's Hospital1 papers (2024–2024)Jeffrey S. Weinberg · Focus (Germany)1 papers (2013–2013)Erik P. Sulman · Duke University1 papers (2013–2013)Jason Beiko · Swedish Research Council for Environment Agricultural Sciences and Spatial Planning1 papers (2013–2013)Sujit S. Prabhu · Texas Medical Center1 papers (2013–2013)Kenneth Aldape · National Institute of Mental Health1 papers (2013–2013)Mark R. Gilbert · BC Centre for Disease Control1 papers (2013–2013)Afshin Salehi · Nebraska Medical Center1 papers (2024–2024)Luke J. Weisbrod · Neurological Surgery1 papers (2024–2024)Surinder K. Batra · Universidad del Noreste1 papers (2024–2024)Maneesh Jain · Universidad del Noreste1 papers (2024–2024)Raymond Sawaya · American University of Beirut Medical Center1 papers (2013–2013)Matthew Cabral · The University of Texas MD Anderson Cancer Center1 papers (2013–2013)— · 1 papers (2024–2024)Vincent Cheung · Centre Hospitalier de l’Université de Montréal1 papers (2013–2013)Kenneth R. Hess · The University of Texas MD Anderson Cancer Center1 papers (2013–2013)Dima Suki · The University of Texas MD Anderson Cancer Center1 papers (2013–2013)